comparemela.com

Latest Breaking News On - Medical gastrointestinal oncology - Page 2 : comparemela.com

Dr Kim on the Investigation of RLY-4008 in FGFR2+ Cholangiocarcinoma

Richard Kim, MD, discusses the investigation of RLY-4008 for the treatment of patients with cholangiocarcinoma harboring an FGFR2 fusion or rearrangement.

Richard kimMoffitt cancer centerGastrointestinal oncology departmentMedical gastrointestinal oncologyNovel therapeutic approaches to target fgfr2 mutations in cholangiocarcinomaOnclive tv

NeoImmuneTech Welcomes New Members to its Scientific Advisory Board

ROCKVILLE, Md., Aug. 8, 2022 /PRNewswire/ NeoImmuneTech, Inc. (NIT or NeoImmuneTech ), a clinical-stage T cell-focused biopharmaceutical compa.

Soult ukpyolsiSouth koreaUnited statesUnited kingdomSan franciscoRafi ahmedRichard kimYoung kwang chaeKeith watsonJohns hopkins universityEmory university school of medicineYonsei university college of medicinePrnewswire neoimmunetech incNorthwestern university feinberg school of medicine illinoisNeoimmunetech incEmory vaccine center

vimarsana © 2020. All Rights Reserved.